BMI View: As a result of lower-than-expected real GDP growth for H116, we have downgraded our shortterm
outlook for Nigeria's pharmaceutical market slightly; however, its long-term growth outlook remains
largely positive. Despite our downgrade, the market is still gro ..."
BMI View: Uganda's public healthcare sector will remain underfunded, and hence underdeveloped, with
the private sector remaining the largest in terms of value. Strong private consumption growth will drive
medicine spending, with opportunities being presented for multi ..."
BMI View: Mauritius' pharmaceutical and healthcare markets are expected to continue on a positive
growth trajectory over the forecast period. Meanwhile, Mauritius' 2016-2017 Budget is set to strengthen
manufacturing capacity in the pharmaceutical sector, including t ..."
BMI View: Namibia's weak domestic manufacturing capabilities and strong colonial ties with South Africa
will ensure the country continues to import the majority of its pharmaceutical needs over the coming years.
Despite a relatively attractive business environment, ..."
BMI View: The Moroccan government's strategy of introducing pharma-clusters in an attempt to
strengthen the domestic pharmaceutical industry will see the market develop into a more attractive
investment destination for multinational drugmakers. The use of pharma-clust ..."
BMI View: Mozambique will continue to be one of the least attractive pharmaceutical and healthcare
markets in the Middle East and Africa region (MEA). The escalation of political violence has directly
impacted health centres in some of the country's provinces leading ..."
BMI View: On the back of robust economic expansion, Cameroon's pharmaceuticals and healthcare sector
will continue experience high growth rates over the forecast period. As the drug market continues to
expand, and spending per capita on medicine increases from its cur ..."
BMI View: Ghana remains an attractive investment prospect for foreign drugmakers operating in Sub-
Saharan Africa, and stabilising the national health insurance scheme provides an upside risk to our outlook
for the pharmaceutical sector. The Ghanaian government is act ..."
BMI View: It is vital that companies that are looking to sell non-communicable disease therapeutics work
alongside the public sector and focus on physician education and patient awareness in a market that has
traditionally focussed on infectious diseases such as malar ..."
BMI View: Algeria's large and growing healthcare and pharmaceutical market will continue to drive
interest from multinational drugmakers over the forecast period. Meanwhile, Algeria's pharmaceutical
exports will continue to expand as the country gradually strengthens ..."